Professor of Neurosurgery
University of Southern California
Los Angeles, California, United States
William Mack is Professor of Neurosurgery, Vice Chair of Academic Affairs, and a faculty member of the Neuroscience Graduate Program at University of Southern California. His area of clinical focus is endovascular and open surgical management of patients with cerebrovascular disease.
Dr. Mack received his Bachelor degree from Cornell University. He then attended Columbia University, College of Physicians and Surgeons, where he graduated from medical school and completed Neurosurgical residency training. During residency, he spent one year as a post-doctoral cerebrovascular research fellowship under Drs. David J. Pinsky and E. Sander Connolly Jr. at Columbia University. Following residency, Dr. Mack completed an Interventional Neuroradiology fellowship at UCLA.
Dr. Mack is the Principal Investigator and Director of the Cerebrovascular Laboratory in the Zilkha Neurogenetic Institute. His overarching academic goal is to examine the effects of inflammation in experimental models of cerebrovascular disease. Dr. Mack is currently the Principal Investigator on active NIH (R01, P01, R21, R25) grants. He serves on the National Advisory Council for the Neurosurgery K12 Neurosurgeon Research Career Development program.
Dr. Mack is the Past President of the Society of Neurointerventional Surgery and the Chair of the Cerebrovascular section of the Congress of Neurological Surgeons/ American Association of Neurological Surgeons. He was an Associate Editor of the Journal of Neurointerventional Surgery, and is an Editorial Board member for the Journal of Neurosurgery and World Neurosurgery. Dr. Mack is a Charter member of the NIH/ NINDS NST-1 study section and a member of the AHA Stroke Scientific Statement Oversight Committee.
(SSC) Introduction of Donaghy Lecture
Sunday, April 23, 2023
3:31pm – 3:33pm PST
Disclosure(s): Borva: Stock Shareholder (excluding mutual funds) (Ongoing); Cerebrotech: Stock Shareholder (excluding mutual funds) (Ongoing); Egret Therapeutics: Advisor (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Endostream: Stock Shareholder (excluding mutual funds) (Ongoing); Imperative Care: Consultant (Ongoing); Kaneka: Consultant (Ongoing); Q'Apel: Advisor (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Radical Catheters: Stock Shareholder (excluding mutual funds) (Ongoing); Spartan Micro: Advisor (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Stream Biomedical: Advisor (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Vastrax: Stock Shareholder (excluding mutual funds) (Ongoing); Viseon: Stock Shareholder (excluding mutual funds) (Ongoing)